Please use this identifier to cite or link to this item:
|Title:||Clinical trial endpoints for optical coherence tomography angiography in neovascular age-related macular degeneration|
|Authors:||Cole, Emily D.|
Novais, Eduardo A.
Louzada, Ricardo Nogueira [UNIFESP]
Waheed, Nadia K.
|Keywords:||optical coherence tomography|
optical coherence tomography angiography
neovascular age-related macular degeneration
|Publisher:||Lippincott Williams & Wilkins|
|Citation:||Retina-The Journal Of Retinal And Vitreous Diseases. Philadelphia, v. 36, n. 12, p. S83-S92, 2016.|
|Abstract:||Purpose: To describe qualitative and quantitative optical coherence tomography (OCT) angiography (OCTA) parameters for choroidal neovascularization (CNV) secondary to age-related macular degeneration (AMD) and their applicability as potential clinical trial endpoints. Methods: A review of current literature related to the topic of OCTA and AMD. Results: There are a number of promising OCTA parameters that can be used to diagnose the presence of CNV and to monitor the activity and progression of the lesion, pre- and post-treatment morphological characteristics, CNV dimensions, and automated quantitative parameters such as vessel density. Conclusion: The OCTA parameters described in this review have promise for the future development of clinical trial endpoints, but require further validation before they can be widely used.|
|Appears in Collections:||Artigo|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.